Abstract:OBJECTIVE To evaluate the efficacy and outcome of palliative transurethral resection of the prostate (pTURP) in patients with server bladder outlet obstruction (BOO) due to prostatic obstruction induced by advanced prostate cancer. METHODS All the 16 patients who had a pTURP between November 2007 and January 2015 due to BOO (high residual urine volume combined with hydronephrosis or urinary retention refractory to medical treatment) at our institution were retrospectively assessed. All the patients were diagnosed with advanced prostate cancer (III stage or IV stage). The clinical data, functional and oncological follow-up results were evaluated. The cancer specific survivals were estimated by Kaplan-Meier analysis. RESULTS The mean age of the patients was 73.8 years (63-81 years). Five cases were graded in stage III of prostate cancer and 11 in stage IV. The indications for pTURP were refractory urinary retention in 12 cases, and high residual urine volume with hydronephrosis in 4 cases. The mean prostate volume at pTURP was 43.2 mL (28-78 mL) and the mean PSA (prostate specific antigen) level before pTURP was 48.2 μg/L (2-107 μg/L). The patients had mean residual urine volume 166.4 mL (50-450 mL) and mean urinary flow rate 3.6 mL/s (0-6 mL/s, n=7) before pTURP. It took mean 62.9 min (35-94 min) in pTURP with mean estimated blood loss 126.9 mL (30-263 mL) and mean resected tissue 14.1 g (10-22 g). There were no transfusion cases. Postoperative mean serum PSA 20.5 μg/L (1-41 μg/L), residual urine volume 43.4 mL (0-400 mL) and urinary flow rate 10.1 mL/s (7-16 mL/s, n=7) were shown in these cases. A patient encountered persistent hematuria needing irrigation. Compared with preoperation, the patients had significantly lower serum PSA level (P<0.001), less residual urine volume (P<0.001) and more urinary flow rate (P=0.001) after pTURP. The mean follow-up after pTURP was 36 months (1-86 months). In addition, 2 patients received repeated pTURP. At the time of the latest analysis, 3 patients died from prostate cancer progression. As estimated by Kaplan-Meier analysis, the 2-, 3- and 5-year cancer specific survival rates after pTURP were 91%, 78% and 58%, respectively. CONCLUSION Despite less resected tissue, greater delay in urination and reoperation rates, pTURP is a fairly effective procedure in patients with server BOO. Although a potential negative impact of pTURP on survival cannot be excluded, the estimated 3- and 5-year cancer specific survival rates in this series seem to justify this intervention.

Experience in treating advanced prostate cancer with bladder outlet obstruction]

TUVP for Treatment of Advanced Prostate Cancer with Bladder Outlet Obstruction

Transurethral prostate resection for advanced prostate cancer in patients with bladder outlet obstruction

High-risk benign prostatic hyperplasia patients treated with transurethral resection of prostate

Long-term Outcome of Transurethral Resection of Prostate in Patients with Advanced Prostate Cancer and Bladder Outlet Obstruction

TUVP combined with total androgen suppression (TAB) in management of advanced prostatic cancer (Report of 32 cases)

Diagnosis and treatment of advanced prostatic cancer(report of 84 cases)

Effect Observation of TURP Combined with Androgen Blockade for Advanced Prostate Cancer with Bladder Outlet Obstruction

Photoselective Laser Vaporization of the Prostate in the Treatment of Bladder Outlet Obstruction in Advanced-Stage Prostate Cancer: a Single-Center Experience.

Clinical Observation of Plasma Kinetic Resection of Prostate Combined with Endocrine Therapy in the Treatment of Advanced Prostate Cancer with Bladder Outlet Obstruction

Clinic Evaluation on TVP with Endocrinal Therapy Treatment of Prostatic Carcinoma with Bladder Outlet Obstruction

Transurethral Vaporization of Prostate Along with Maximal Androgen Blockade for Prostate adenocarcinoma

Green Laser Photoselective Vaporization of the Prostate Along with Maximal Androgen Blockade for Advanced Prostate Cancer

Transurethral vapor-resection of prostate combined with epididymal sparing bilateral simple orchiectomy for advanced prostate cancer patients with bladder outlet obstruction

Thulium laser resection of prostate and antiandrogen therapy in treatment of patients with advanced prostatic cancer accompanied by bladder outlet obstruction

[Efficacy and Outcome of Palliative TURP in Patients with Bladder Outlet Obstruction Induced by Advanced Prostate Cancer].

[TURP plus endocrine therapy (ET) versus α1A-blockers plus ET for bladder outlet obstruction in advanced prostate cancer]

Photoselecticve Vaporization of the Prostate with Potassium-Titanyl-phosphate Laser in the Treatment of Lower Urinary Tract Obstruction Caused by Advanced Prostate Cancer

Tamsulosin application for the treatment of advanced prostate cancer accompanied with bladder outlet obstruction

Transurethral Resection of the the Prostate for Lower Urinary Tract Obstruction from Advanced Prostate Cancer

Transurethral plasmakinetic prostatectomy combined with hormone therapy for lower urinary tract obstruction caused by advanced prostate cancer